BCL2 and breast carcinoma: There are a few reports (see Table 1), in which prognostic potential of BCL-2 expression was investigated in the breast cancer patient groups consisting of subgroups of women treated with ATC in adjuvant setting, although in all these studies, expect one (Abdel-Fatah et al. 2010) not analysed separately.